Screening of bone-related microRNAs in serum of patients with osteogenesis imperfect.
- Author:
Ziqiang WANG
1
;
Yanqin LU
;
Xiuzhi REN
;
Yanzhou WANG
;
Zhiliang LI
;
Chao XU
;
Jinxiang HAN
Author Information
1. Shandong Medicinal Biotechnology Center, Shandong Academy of Medical Sciences, Jinan 250062, Shangdong, China.
- Publication Type:Journal Article
- MeSH:
Biomarkers;
blood;
Case-Control Studies;
Child;
Female;
Gene Expression Profiling;
Gene Expression Regulation;
Humans;
Male;
MicroRNAs;
blood;
genetics;
Osteogenesis Imperfecta;
blood;
genetics
- From:
Chinese Journal of Biotechnology
2012;28(10):1245-1252
- CountryChina
- Language:Chinese
-
Abstract:
We screened differential expression bone-related microRNAs (miRNAs) in serum of patients with osteogenesis imperfect (OI). First, we selected the reference gene (s) fit for quantitative detection of serum miRNAs by using geNorm and several other programmes. Then real-time fluorescent quntitative PCR was used to detect the expression level of bone-related miRNAs gained by means of miRanda, Targetscan and Pictar softwares caculation and reading literature. Then, the results were analyzed with the matched t test. All 6 candidate reference genes had a stable expression level in serum of healthy controls and patients with different characters, and the optimal number of reference genes is 4 (miR-16, let-7a, snRNAU6, miR-92a) after Pairwise Variations analysis (V4/5 = 0.133 < 0.15). For validating the universality of expression stability, we detected the relative expression value of miR-16, let-7a, snRNAU6 and miR-92a in another 8 healthy controls and 16 patients with OI and the result revealed that the expression of 4 genes remained stable (M < 1.5). After measuring serum levels of more than 100 bone-related miRNAs in patients with real-time qPCR, 11 miRNAs showed differential expression, and bioinformatic analysis suggested these altered expressional mioRNAs had possibilities to participate in the process of OI. So the experiment indicated that there existed many differential expression bone-related miRNAs in serum of patients with OI, and these miRNAs had potentials to be promising biomarkers for serologic tests and diagnosis of OI.
